BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17

• Press Releases

  Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

  June 15, 2026

   · 

  9 min read
• Press Releases

  OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026

  June 15, 2026

   · 

  5 min read
• Press Releases

  Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

  June 15, 2026

   · 

  11 min read
• Press Releases

  Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

  June 15, 2026

   · 

  10 min read
• Press Releases

  Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

  June 15, 2026

   · 

  15 min read
• Press Releases

  CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026

  June 15, 2026

   · 

  6 min read
• Press Releases

  CEL-SCI Corporation Announces Pricing of Offering

  June 15, 2026

   · 

  3 min read
• Press Releases

  Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

  June 15, 2026

   · 

  3 min read
• Press Releases

  2026 EHA | Over 40 Orelabrutinib Studies Presented, Including First Clinical Data from Europe and US TN CLL/SLL Patients

  June 15, 2026

   · 

  6 min read
• Press Releases

  Akeso’s Next-Generation HER3 ADC AK138D1 Combined with Ivonescimab: First Patient Enrolled in Phase Ib/II Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy

  June 15, 2026

   · 

  6 min read